VEGF Trap-Eye (BAY86-5321)
Sponsors
Bayer
Conditions
Diabetes MellitusMacular EdemaMyopia, Pathological
Phase 3
VEGF Trap-Eye in Choroidal Neovascularization Secondary to Pathologic Myopia (mCNV)
CompletedNCT01249664
Start: 2010-12-31End: 2013-08-31Updated: 2014-05-05
Intravitreal Aflibercept Injection in Vision Impairment Due to DME
CompletedNCT01331681
Start: 2011-05-09End: 2015-03-30Updated: 2023-11-27
Japanese Safety Study of VEGF Trap-Eye in DME (Diabetic Macular Edema)
CompletedNCT01512966
Start: 2012-01-31End: 2013-09-30Updated: 2014-10-09